Sara Bonstein, Chief Financial Officer at INSMED Inc (INSM), sold 18,321 shares at $80.00 ($1.5M) on 2025-02-11, disclosed to the SEC on 2025-02-13.
Scheduled sale ($1.5M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.00 | 13,302 | $1.1M | 72.6% |
| 2 | $80.00 | 5,019 | $402K | 27.4% |
| Total | $80.00 avg | 18,321 | $1.5M | 100% |
| Filing → |
| INSM | SELL | 2026-02-04 | $117K | — | Filing → |
| INSM | SELL | 2026-01-08 | $809K | — | Filing → |
| INSM | SELL | 2025-07-23 | $12.0M | — | Filing → |